1-4 of 4
Dana Provaznikova
Close
Sort by
Journal Articles

Fli-1 and EKLF Gene Expression in Patients with MDS 5q- Syndrome.

Radana Neuwirtova, MD, PhD, Ota Fuchs, V, Dana Provaznikova, Jr., Jaroslav Cermak, V, Magda Siskova, III, Anna Jonasova, V, Kyra Michalova, IV
Journal: Blood
Blood (2009) 114 (22): 2788.
https://doi.org/10.1182/blood.V114.22.2788.2788
Published: 2009
Journal Articles

A Lack of Correlation between EVI1 Expression, MDS Subtype and Karyotype Abnormalities Suggests Multiple Pathways Involved in EVI1 Impact on Hematopoietic Cells in MDS Patients.

Jaroslav Cermak, MD, PhD, Ota Fuchs Ing, PhD, Dana Provaznikova, PhD, Kyra Michalova, PhD, Dana Mikulenkova, MD, Jana Brezinova, RNDr PhD, Pavel Klener, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2441.
https://doi.org/10.1182/blood.V110.11.2441.2441
Published: 2007
Journal Articles

Differential Induction of Apoptosis in Human Leukemia Cells (ML-1, ML-2, CTV-1 and KASUMI-1) Exposed to the Proteasome Inhibitor Bortezomib and the Effect of Transforming Growth Factor-beta Signaling Pathway.

Ota Fuchs, PhD, Dana Provaznikova, MS, Gabriela Peslova, MS, Marcela Kocova, MS, Iuri Marinov, MD, Ivan Spicka, MD
Journal: Blood
Blood (2006) 108 (11): 4359.
https://doi.org/10.1182/blood.V108.11.4359.4359
Published: 2006
Journal Articles

Increased Expression of Genes for Protooncoproteins SnoN and SnoA in Human Myeloblastic Leukemia ML2 Cells and Resistance of ML2 Cells to Transforming Growth Factor-beta-Induced Growth Arrest.

Ota Fuchs, Gabriela Peslova, Dana Provaznikova, Iuri Marinov
Journal: Blood
Blood (2005) 106 (11): 4347.
https://doi.org/10.1182/blood.V106.11.4347.4347
Published: 2005